Many patients suffering from psoriasis showed significant recovery after just a single dose of an experimental treatment with a human antibody that blocks an immune signaling protein crucial to the disease, researchers report. ...
Mar 13, 2015
0
155
SARS-CoV-2, the virus that causes COVID-19, has continuously mutated since it emerged in late 2019. This rapid evolution poses challenges for vaccines and treatments designed to target the virus. A booster shot is now needed ...
Apr 16, 2022
0
4
The New England Journal of Medicine (NEJM) today published final results of a nationwide multicenter study led by researchers at Johns Hopkins Medicine and the Johns Hopkins Bloomberg School of Public Health that show plasma ...
Mar 30, 2022
0
294
A new study led by Queen Mary University of London has demonstrated the effectiveness of using a novel light technology to monitor the presence of anti-drug antibodies in the treatment of multiple sclerosis (MS), which can ...
Jun 4, 2020
0
1
Patients with thyroid eye disease who used the minimally invasive insulin-like growth factor I blocking antibody, teprotumumab, experienced improvement in their symptoms, appearance and quality of life, according to a study ...
Feb 10, 2020
0
5
A new class of immunotherapy shows promising results for fighting the most aggressive form of skin cancer.
Apr 25, 2023
0
72
Intensive treatment for patients with Crohn's disease showed no safety differences compared to the current standard of care, according to a trial published in the journal Gastroenterology.
Mar 2, 2022
0
6
Antibodies aren't the only immune cells needed to fight off COVID-19—T cells are equally important and can step up to do the job when antibodies are depleted, suggests a new Penn Medicine study of blood cancer patients ...
May 27, 2021
0
21
University of Virginia cell biologist John Herr believes that the most ground-breaking findings always start with an insight built on basic science. He would know; his steady research on the development of sperm and eggs ...
Oct 30, 2015
1
61
University of Queensland researchers have produced batches of a monoclonal antibody, which may offer hope as a potential therapeutic for Hendra virus infection in humans.
Jul 12, 2011
0
0
